Mast Cell Leukemia Global Clinical Trials Review, H2, 2016

GlobalDataが出版した調査資料(GDHC3723CTIDB)・商品コード:GDHC3723CTIDB
・発行会社(調査会社):GlobalData
・発行日:2016年8月30日
・ページ数:48
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Mast Cell Leukemia Global Clinical Trials Review, H2, 2016
Summary

GlobalData’s clinical trial report, “Mast Cell Leukemia Global Clinical Trials Review, H2, 2016″ provides an overview of Mast Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Mast Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Mast Cell Leukemia to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Mast Cell Leukemia to Oncology Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Mast Cell Leukemia Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profile Snapshots 25
Appendix 45
Abbreviations 45
Definitions 45
Research Methodology 46
Secondary Research 46
About GlobalData 47
Contact Us 47
Disclaimer 47
Source 48

List of Tables
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2016* 5
Mast Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Mast Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Mast Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Mast Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Mast Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Mast Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Proportion of Mast Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 12
Mast Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Mast Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Mast Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 15
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2016* 16
Mast Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 17
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 18
Mast Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 19
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 20
Mast Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 21
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 22
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 23
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 24

★調査レポート[Mast Cell Leukemia Global Clinical Trials Review, H2, 2016] (コード:GDHC3723CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[Mast Cell Leukemia Global Clinical Trials Review, H2, 2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆